Soluble immune response suppressor (SIRS), a protein ofMr 14,000, is a lymphokine produced by interferonor concanavalin A-activated suppressor T cells and is oxidized to its activated form, SIRS01, by H202 produced by macrophages. SIRS01 inhibits antibody secretion by B lymphocytes and cell division by normal or transformed cell lines. Effects of purified growth factors on suppression of antibody secretion were examined to determine whether any would oppose the inhibitory effects of SIRS or SIRSO.. Interleukin 1 (IL-1), interleukin 2 (IL-2), and epidermal growth factor (EGF) each inhibited SIRS-mediated suppression of antibody secretion by cultured mouse spleen cells. Inhibition of SIRS activity was most effective when growth factors were added late in the culture period. IL-1, IL-2, and EGF also blocked suppression by SIRSOx. However, EGF and IL-1 blocked suppression by SIRSOI only when added 3-6 hr before addition of SIRS*1, whereas IL-2 blocked suppression by SIRS01 when added before or up to 3 hr after addition of SIRS01. Further evaluation showed that IL-2, but not EGF or IL-1, reversed inhibition of antibody secretion by SIRSOI in a time-and concentrationdependent manner. With 50 units of IL-2 per 0.5-ml culture, reversal was complete within 1 hr. The ability of growth factors to interfere with inhibition of cell division by SIRS0x was examined with the human B-cell leukemia RPMI-1788. This cell line binds EGF but is not known to have cell surface receptors for IL-1 or IL-2. EGF (0.3-1 ng/ml), when added to RPMI-1788 cultures 4-6 hr before SIRS0x, interfered with the ability of SIRS0x to inhibit cell division. Taken together, these data indicate that growth factors interfere with both the immunosuppressive and growth inhibitory properties of SIRS01 in both heterogeneous and homogeneous cell populations.
SIRS01 in both heterogeneous and homogeneous cell populations.
In many instances, regulation of biological activities is governed by processes that activate or inhibit a given pathway. Examples include allosteric regulation of enzyme activity, inhibition of gene transcription by proteins encoded by closely linked genes, and regulation of activities of cells or organs by hormones with opposing effects. In the immune system, antigen-specific and antigen-nonspecific regulatory proteins that either promote or inhibit immune function have been well documented and characterized. To explore the possibility that these inhibitory and stimulatory proteins may act antagonistically, two reasonably well-characterized classes of antigen-nonspecific growth-stimulatory and growth-inhibitory proteins were tested for their effects on production of antigen-specific antibody responses in vitro.
Soluble immune response suppressor (SIRS) is a protein (Mr 14,000) produced by mitogen-or interferon-activated suppressor T cells that inhibits antibody secretion by B lymphocytes and cell division by neoplastic cell lines (1) (2) (3) (4) (5) . Before SIRS can inhibit cellular functions it must be activated to SIRSOX by peroxide (4, 5) . SIRSox appears to derive its inhibitory properties from its ability to mediate oxidation of 30-40%o of cellular protein sulfhydryls (6) and, in particular, to disrupt the normal intracellular array of microtubules (7). This is not surprising, since microtubule integrity is sensitive to sulfhydryl-modifying agents (8) . Further, inhibition of cell division or antibody secretion by SIRSoX is reversed by sulfhydryl-reducing agents such as 2-mercaptoethanol or dithiothreitol (3, 5, 6) . Interleukin 1 (IL-1) is a product of activated macrophages that stimulates the proliferation, maturation, and functional activity of a broad spectrum of cell types (9) (10) (11) and the rapid production of interleukin 2 (IL-2) by T lymphocytes (12) and that may participate in the initiation and amplification of a variety of immune responses (13) . IL-2 stimulates cell division by activated T lymphocytes (14, 15) , T-cell differentiation (16) , and lymphokine production by T lymphocytes (17, 18) . Results obtained with monoclonal antibodies to the murine IL-2 receptor have suggested that activated B cells also have IL-2 receptors on their cell surface (18) , and other studies have suggested that IL-2 may participate in the differentiation of B lymphocytes in the apparent absence of T lymphocytes (19) . The ability of IL-1 to stimulate proliferation by T lymphocytes appears to be due to its ability to stimulate IL-2 production (20) . Epidermal growth factor (EGF) is a polypeptide hormone that plays an essential role in the regulation of cell division and differentiation (21) . Activated B cells and some transformed B-cell lines have been shown to bind EGF (22) .
The results reported here show that growth factors inhibit both the immunosuppressive and the growth-inhibitory properties of SIRS or SIRSox in both heterogeneous and homogeneous cell populations. (12) . Between 0.8 and 1.6 units of IL-2 (Amgen) maintained growth of the IL-2-dependent cell line HT-2 in a standard 24-hr culture assay (14) . Stimulation of fibroblast proliferation in medium containing a low concentration of serum was obtained with 1-10 ng of EGF/ml.
MATERIALS AND METHODS

RESULTS
Effect of Time of Addition of Growth Factors on SIRS-
Mediated Suppression. Although SIRS must be added to cultures at initiation to suppress PFC responses, suppression is not observed until days 4 and 5 of the culture period. To determine the effects of growth factors on SIRS-mediated suppression, IL-1, IL-2, or EGF was added to SIRS-treated cultures at various times during the culture period. Fig. 1 shows that addition of IL-1 (2 units) IL-2 (5 units), or EGF (3 ng) on day 4 of the culture period almost completely blocked suppression by SIRS. SIRS (10 units) suppressed responses 90%; addition of IL-2 or EGF on day 4 reduced suppression to only 20%, and IL-1 reduced suppression to 33%. Addition of IL-1, IL-2, or EGF on days 0-3 to cultures treated with SIRS (10 units) was less effective but EGF was somewhat more effective than IL-1 or IL-2. However, where suppression by SIRS was incomplete (1 unit of SIRS gave 52% suppression) addition of IL-1 or IL-2 earlier in the culture period yielded significant inhibition of suppression. These data indicate that IL-1, IL-2, and EGF block SIRS-mediated suppression and are more effective when added late in the culture period. (Fig. 4) or IL-2 for 6 hr, SIRSOX (10 units/ml), was added, and the cultures were incubated for an additional 24 hr. At this time,
cultures were harvested and cell number was determined by using a hemocytometer. Cell number in control cultures or cultures treated with growth factors increased from 3.0 x 105 per ml to 6.5 X 105 per ml while in cultures treated with SIRSOX, cell number increased from 3.0 x 105 per ml to 3.4 x 105 per ml. Fig. 6 shows the effects of growth factors on SIRSox-mediated inhibition of tumor cell division. EGF at 0.3-10 ng/ml completely prevented inhibition of division by SIRSOX In contrast, IL-1 did not interfere with the inhibitory activity of SIRSOX, and IL-2 interfered only slightly at the highest concentration tested (400 units/ml).
To prevent suppression of PFC responses by SIRSO, EGF or IL-1 have to be added 3-6 hr before addition of SIRSOX, whereas IL-2 can be added up to 3 hr after SIRSOX and still effectively prevent suppression. To determine when EGF had to be added to RPMI-1788 cells to effectively interfere fibroblasts by EGF is probably the best-characterized example of this phenomenon (27, 28) . IL-2 stimulates division by T-cell clones or lines as well as by heterogeneous T-cell populations (14, 15) . It appears that most of the growthpromoting properties of IL-1 result from its ability to stimulate production of IL-2 in heterogeneous T-cell populations (20) . It has been shown that IL-2 activates antigen-nonspecific suppressor T cells (29) and may also participate in the differentiation of B lymphocytes in the apparent absence of T lymphocytes (18) . Further, studies with monoclonal antibodies against the murine IL-2 receptor have suggested that activated B cells have IL-2 receptors on their surface (19) . Experiments described here do not directly address the mechanism by which growth factors interfere with the inhibitory properties of SIRSO0. It Inhibition of tumor cell division by SIRSOX appears to be mediated by oxidation of some protein sulhydryls (6) . In particular, SIRSOX disrupts intracellular microtubules in both normal and transformed cell lines (7). Thus, it will be important to determine whether growth factors interfere with SIRS0x-mediated oxidation of cellular protein sulfhydryls or disruption of intracellular microtubules in both homogeneous and heterogeneous cell populations. Further examination of the opposing effects of growth factors and suppressor factors may improve the understanding of the biological roles of these mediators in governing immune responses and cell proliferation in general.
